glp-1 heart muscle and insulin regulation of skeletal and cardiac microvascular perfusion in type 2 diabetes GLP-1 actions in peripheral tissues.

Amylin therapies Some drugs currently in development take a different approach, targeting receptors for a different hormone: amylin, which is co-secreted, alongside insulin, by the pancreas to slow gastric emptying, suppress glucagon secretion and signal feelings of fullness

Its precision enables improved efficacy, making agonists important in modern drug development strategies across therapeutic areas requiring high specificity

just be mindful of the side effects.

doi: 10.1016/j.amjmed.2023.07.016

Helmstdter J, Keppeler K, Kster L, Mnzel T, Daiber A, Steven S (2022) Glucagon- like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor

Samols, Marks